pharmaphorum

FEBRUARY 11, 2022

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. billion takeover of Clementia Pharma in 2019. billion of its revenues last year.

Sales 103

Sales Pharma Companies Branding Cosmetics 103

World of DTC Marketing

JANUARY 1, 2022

3hree: Pharma will increase its spending in digital, but a lot of the money will be wasted. Studies show that tens of millions of dollars are being wasted due to fraud with programmatic advertising, but many pharma companies are still wasting money on the channel. Invest in product websites with content and usability studies.

Marketing 244

Marketing Doctors Doctor FDA Approval 244

pharmaphorum

FEBRUARY 23, 2022

The Japanese drugmaker will get access to Code Bio’s 3DNA non-viral genetic medicine delivery platform, initially for a liver-directed programme, and is also interested in deploying the technology for central nervous system disorders.

Gene Therapy 105

Gene Therapy Gene Gene Sequencing Immune Response 105

XTalks

AUGUST 21, 2023

This attachment halts the advancement of the genetic disorder through a reduction in the formation of fresh, abnormal bone growth. The active ingredient in Sohonos, palovarotene, functions as an agonist of the retinoic acid receptor gamma, which is present in cells that are involved in bone formation.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

pharmaphorum

DECEMBER 16, 2020

Episode four of Kantar Health’s Health Heroes podcast tackles pharma’s rare disease challenges, the role of patient registries and hears a moving story about the rare genetic disorder Tay-Sachs disease. The podcast finishes up with an overview from Geneviève on the current outlook for rare diseases.

Life Science 52

Life Science Pharma Companies Genetics Research 52

pharmaphorum

OCTOBER 18, 2022

” GSK already scores pretty well among the top 14 pharma companies when it comes to R&D efficiency – ranking third behind Pfizer and Novartis in an analysis of R&D productivity published last year, which looked at the last 20 years of activity.

Production 52

Production Clinical Trials Clinical Trials Genome 52

pharmaphorum

JULY 7, 2022

As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Recent progress in immunotherapy, targeted therapies, and genetic testing has allowed physicians to treat breast cancer more precisely, says Daiichi Sankyo’s Markus Kosch.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

World of DTC Marketing

JANUARY 24, 2022

To them, a big payday is a small biotech firm being acquired by a big ten pharma company. When they tell small biotech companies to cut costs, there will often be a significant delay in getting the drug to market or massive layoffs of needed staff. Venture capitalists often don’t look that far forward.

Life Science 225

Life Science Drugs Genetic Disease Development 225

Drug Discovery World

AUGUST 3, 2023

In the first article, Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. ” and “ Why a recent advancement is a giant leap for human genomics ”.

Big Data 52

Big Data Genome Genomics Pharma Companies 52

pharmaphorum

FEBRUARY 16, 2021

UK biotech Exscientia has signed a string of partnerships with pharma companies and other research-based organisations to apply its AI-based drug discovery platform. It is vital that we develop treatments that target neuroinflammatory mechanisms underlying dementia.”.

Research 119

Research Drugs Protein Development 119

pharmaphorum

APRIL 7, 2022

Novartis’ generics unit Sandoz has moved on to the next stage of a collaboration with Ares Genetics, which is focusing on the use of artificial intelligence to track antimicrobial resistance (AMR), improve diagnoses and guide the most effective use of antibiotics.

Bioinformatics 52

Bioinformatics Genetics Genome Genomics 52

pharmaphorum

JANUARY 18, 2022

Workshop Leader: Wendy Rowan, Scientific Director, Novel Human Genetics, GSK. Biotech / Pharma Companies – Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist.

In-Vitro 52

In-Vitro Engineer Drugs Pharma Companies 52

pharmaphorum

FEBRUARY 17, 2021

One group excelling in this space is the Genetic Alliance. Their work ranges from developing new services in partnership with the National Health Service (NHS) to working with the All Party Parliamentary Group on Rare, Genetic and Undiagnosed Conditions, and the Department of Health on the UK Strategy for Rare Diseases.

Life Science 98

Life Science Branding Genetics Trials 98

pharmaphorum

FEBRUARY 18, 2021

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

pharmaphorum

JANUARY 6, 2021

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. — Tinglong Dai (@TinglongDai) January 5, 2021.

DNA 116

DNA Branding Vaccination Vaccine 116

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. Biotech and AI companies founded by purely tech professionals often opt to bring in pharma executives with insider knowledge further down the line.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

pharmaphorum

MAY 4, 2022

Once selected, Quris can in-license them, progress them through to phase 1 trials and, those that succeed, can be licensed to pharma companies. Once the initial drug candidate is licensed to a pharma company, the profits are then shared with the academic institution or biotech from which Quris originally licensed the drug.

Drugs 143

Drugs Licensing Licensing Pharma Companies 143

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

AUGUST 23, 2021

The vaccine may be a latecomer to the COVID-19 vaccine arsenal, but its approval signals the potential of DNA vaccines and is a boost to companies working in this space. The company also says that it can update the vaccine very easily to deal with mutations in the virus.

DNA 98

DNA Vaccination Vaccine Genetic Engineering 98

pharmaphorum

NOVEMBER 30, 2020

“Our belief is that patients should understand the challenges associated with drug development and how those challenges impact them personally… It is emotionally challenging for patients who must put their faith in the hands of pharma companies”.

Gene Therapy 105

Gene Therapy Gene Antibody Clinical Trials 105

pharmaphorum

OCTOBER 12, 2022

Overall, the aim is to improve the efficiency of drug discovery by identifying genetic variants that contribute to human disease in omics data – a broad category that includes DNA profiles, gene transcripts, and protein expression.

Genome 64

Genome Genomics DNA Drugs 64

XTalks

DECEMBER 20, 2023

Check out this article to learn about the biotech companies that went public this year. The companies include a diverse range engaged in innovative approaches in areas like oncology, genetic medicines, inflammatory diseases, dermatology and cardiorenal therapy.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

DECEMBER 21, 2020

It’s the first major partnership for Janux, which was set up in 2017, and could be the last to be organised by Merck’s R&D head Roger Perlmutter who is retiring from the big pharma company at the end of the year. billion deal with Seattle Genetics covering ADCs for breast cancer and other solid tumours.

Immune Response 59

Immune Response Sales Antibody Pharma Companies 59

pharmaphorum

JUNE 16, 2021

In the US, Ambrx has started recruiting patients into a phase 2 study involving patients previously treated with other HER2 drugs including Roche’s Kadcyla (trastuzumab emtansine), AstraZeneca/Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) or Seattle Genetics orally-active Tukysa (tucatinib).

Sales 59

Sales Antibody Drugs Pharma Companies 59

pharmaphorum

JUNE 2, 2021

Analysts think that it could eventually top $11-$12 billion with additional approved indications, but the drug’s success to date means pharma companies are scrambling to claim a slice of the atopic dermatitis pie. ” The post Amgen pays Kyowa $400m upfront for OX40 eczema drug appeared first on.

Drugs 52

Drugs Licensing Licensing Sales 52

pharmaphorum

NOVEMBER 23, 2021

GSK’s head of research, John Lepore, said there is “compelling genetic evidence” showing that reduced HSD17B13 function confers protection to the liver from inflammatory injury that is a characteristic of NASH. Arrowhead said the partnering process for ARO-HSD was competitive and GSK was one of several suitors for the drug.

Sales 52

Sales Drugs Trials RNA 52

pharmaphorum

DECEMBER 21, 2020

As it’s just a messenger molecule, it does not affect the body’s own genetic code when it is injected as a vaccine – but what it does do is instruct cells to code for copies of a certain protein. Their technology is based on synthetic messenger RNA – short for ribose nucleic acid – which is a short transcript of a longer DNA code.

Vaccination 111

Vaccination Vaccine Doctors Doctor 111

pharmaphorum

MARCH 28, 2022

Built under a government tender, AION Labs comprises four large international pharma companies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. But it always starts with the biology or the genetic pool that makes the natural antibodies. The partnership.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

pharmaphorum

SEPTEMBER 11, 2020

Analysts at Pharma Intelligence decided to find out, surveying professionals involved in clinical data management. Their pool of 155 respondents comes from large pharma companies, biotech companies, device developers, and contract research organisations worldwide. What does this mean for clinical trials?

Trials 98

Trials Clinical Trials Clinical Trials Pharma Companies 98

pharmaphorum

JANUARY 29, 2021

Since Macrae joined the company just four years ago, Sangamo has more than tripled its staff and raised $1.6 It has also built its own manufacturing site and launched partnerships with six big pharma companies. And ultimately we will be able to add genetic influences to diseases that don’t have a genetic cause.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

Pharmaceutical Technology

JUNE 15, 2023

Pharma companies need tools like AI that can reliably improve this percentage without jeopardizing safety. Cutting-edge pharma companies are also using AI to detect patterns within the vast amounts of data generated by clinical trials. Food and Drug Administration approval.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Delveinsight

AUGUST 4, 2021

Similarly, genetics, immune response, and environmental factors also influence the occurrence of Neurological Conditions. With the advancement in technology, today diagnostics testing such as neurological examination, brain scans, genetic screening, and other tests are available to examine the occurrence of Neurological Conditions.

Marketing 98

Marketing Genetics Development Clinical Development 98

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. This will also mean the industry needs to think about how HCPs will want to interact with pharma companies. “If

Pharma Companies 111

Pharma Companies Insulin Packaging Packaging 111

pharmaphorum

JUNE 20, 2022

Some could say that when you think of a rare disease that conjures up images of super-rare genetic conditions, rather than things like oncology, which are areas that attract a lot of interest, and often designations,” Verdin states. . “Some things highlighted in the Report are the growth in the actual budgetary impact of drugs.

Drugs 52

Drugs Marketing Life Science Regulation 52

Drug Discovery World

DECEMBER 14, 2023

Glasgow is also an important centre for the MRC National Mouse Genetics Network, which aims to integrate mouse genetics, cell and tissue systems and deep phenotyping with human data, and develop preclinical platforms that facilitate the rapid translation of mouse data into the clinic.

Drugs 75

Drugs Life Science Research Scientist 75

pharmaphorum

AUGUST 10, 2020

This research also shows the complex system that drives our health outcomes, including the environment, our genetics and our social circumstances. Personalisation : creating interventions based on individuals knowing their genetics, biology and psychology as well as their social and geographical environment.

Genetics 124

Genetics Drug Delivery Research Pharma Companies 124

Delveinsight

SEPTEMBER 27, 2021

Furthermore, the condition carries the risk of differential diagnosis as more than 50 genetic/metabolic diseases are associated with infantile spasms, and many patients have other disorders that cause developmental delays (e.g., Early diagnosis is necessary for better treatment outcomes. cerebral palsy, Down syndrome, tuberous sclerosis, etc.)

Marketing 77

Marketing Hormones Radiology Pharma Companies 77